TC BioPharm (Holdings) plc
TCBPDelisted Aug 8, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001872812
TC BioPharm (Holdings) plc was delisted on Aug 8, 2025; its insiders filed their last Form 4 on Jan 11, 2023; 12 institutions reported holding it in 13F filings for Q3 2023, worth $179.6K in total; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding TC BioPharm (Holdings) plc changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 8 | 8 | 0 |
| Shares | 93.5K | 9.32K | −84.2K (−90.0%) |
| Value | $77.0K | $48.9K | −$28.1K (−36.5%) |
New holders (5)
Institutions that held TC BioPharm (Holdings) plc at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| FNY Investment Advisers, LLC | 8,200 | $43.0K | 0.02% |
| Harbour Investments, Inc. | 236 | $1.24K | 0.00% |
| New England Capital Financial Advisors LLC | 201 | $1.06K | 0.00% |
| Morgan Stanley | 90 | $473 | 0.00% |
| Sanctuary Wealth Management, L.L.C. | 12 | $63 | 0.00% |
Sold out (5)
Institutions that held TC BioPharm (Holdings) plc at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Platform Technology Partners | 50,000 | $41.2K |
| Citadel Advisors LLC | 22,528 | $18.5K |
| Csenge Advisory Group | 12,000 | $9.89K |
| UBS Group AG | 2,101 | $1.73K |
| Headlands Technologies LLC | 3 | $2 |